Wednesday 23 April 2025

Pharma & Biotech Start-up & Scale-up News

Featured

Werewolf Therapeutics
An innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.
Pharmaceutical
Lexicon Pharma soars as it licenses LX9851 to Novo Nordisk
28 March 2025
Pharmaceutical
Lexicon pivots back to pipeline after FDA rejection
25 November 2024

Latest Ones To Watch News

Biotechnology
iBio adds to cardiometabolic and obesity pipeline with AstralBio deal
22 April 2025
Biotechnology
Halda Therapeutics appointments CMO
22 April 2025
Biotechnology
Ono and Jorna jump into research collab on RNA editing
22 April 2025
More ones to watch news >
Reset all filters
Refine Search
Opthea
Opthea
OncoZenge
OncoZenge
Axsome Therapeutics
Soleno Therapeutics
GAIA
Alligator Bioscience
Pliant Therapeutics
Nuvation Bio
Enanta Pharmaceuticals
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma
SFA Therapeutics
Reunion Neuroscience


Today's issue

Regeneron latest to go big on US manufacturing
Biotechnology
Regeneron latest to go big on US manufacturing
22 April 2025
Biotechnology
iBio adds to cardiometabolic and obesity pipeline with AstralBio deal
22 April 2025
Biotechnology
NICE recommends NHS use of Opdivo and Yervoy combo for mCRC
22 April 2025
Biotechnology
Halda Therapeutics appointments CMO
22 April 2025
Biotechnology
MHRA nod for Hympavzi for hemophilia A or B
22 April 2025
Pharmaceutical
Harvard sues Trump over frozen research funding
22 April 2025
Pharmaceutical
Roche to invest $50 billion in US production
22 April 2025

Company Spotlight

An innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.




Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze